3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Classical hematology
1
Conditions
Pancreatic Neoplasms
15
Neoplasms
11
Multiple Myeloma
9
Colorectal Neoplasms
8
Myelodysplastic Syndromes
7
Leukemia, Myeloid, Acute
6
Glioblastoma
5
Sarcoma
4
Prostatic Neoplasms
4
Neoplasms, Plasma Cell
4
Leukemia, Myelomonocytic, Chronic
4
Carcinoma, Non-Small-Cell Lung
4
Inflammation
3
Breast Neoplasms
3
Stomatitis
2
Stomach Neoplasms
2
Skin Neoplasms
2
Primary Myelofibrosis
2
Ovarian Neoplasms
2
Neoplasms by Site
2
Myofibroma
2
Myeloproliferative Disorders
2
Lymphoma
2
Lung Neoplasms
2
Liver Neoplasms
2
Leukemia
2
Glioma
2
Frailty
2
Digestive System Neoplasms
2
Digestive System Diseases
2
Interventions
Biopsy
2
thymoglobulin
1
fludarabine phosphate
1
fludarabine
1
epacadostat
1
decitabine and cedazuridine drug combination
1
Vitamin B 12
1
Specimen Handling
1
Sertraline
1
Pluvicto
1
Peripheral Blood Stem Cell Transplantation
1
Metformin
1
Immunotherapy, Adoptive
1
IDO-1 inhibitor LY3381916
1
Granulocyte Colony-Stimulating Factor
1
Genetic Counseling
1
Folic Acid
1
Filgrastim
1
Exercise
1
Emapalumab
1
Cyclophosphamide
1
Cord Blood Stem Cell Transplantation
1
Busulfan
1
Bone Marrow Transplantation
1
Ascorbic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Cytopenia
×
Ascorbic Acid
×
Clear all
NCT03682029
2024-04-17
EVITA
Rigshospitalet, Denmark
Phase NA
Unknown
109 enrolled